Tag: endpoint

July 22, 2018

5 Top Weekly NASDAQ Biotech Stocks: MiMedx Group Leads

MiMedx Group, Avid Bioservices, Lifevantage, EyePoint Pharmaceuticals and BioLife Solutions were last week's top gainers on the NASDAQ Biotechnology Index.
July 15, 2018

5 Top Weekly NASDAQ Biotech Stocks: Arbutus on Top

Adamis Pharmaceutical, Juniper Pharmaceuticals, Anavex Life Sciences, Arbutus BioPharma and Soleno Therapeutics were last week's top gainers on the NASDAQ...
July 1, 2018

5 Top Weekly NASDAQ Biotech Stocks: Avid Bioservices on Top

Avid Bioservices, Arbutus Biopharma, Catalyst, ArQule and CTI BioPharma were last week's top gainers on the NASDAQ Biotechnology Index.
June 10, 2018

5 Top Weekly NASDAQ Biotech Stocks: MEI Pharma on Top

MEI Pharma, Anavex Life Sciences, Trillium Therapeutics, Celldex Therapeutics and Ophthotech were last week's top gainers on the NASDAQ Biotechnology...
May 16, 2018

10 Top Cybersecurity Companies

The cybersecurity industry is quickly expanding in response to the need for increased computer security. Here are the 10 top...
May 13, 2018

5 Top Weekly NASDAQ Biotech Stocks: Helius Up 43.19 Percent

Helius Medical Technologies, vTv Therapeutics, Second Sight Medical Products, Depomed and Senomyx were last week's top gainers on the NASDAQ.
May 9, 2018

Reata Pharmaceuticals Announces First Quarter 2018 Financial Results and an Update on Development Programs

Reata Pharmaceuticals (Nasdaq:RETA), a clinical-stage biopharmaceutical company, today provided an update on the Company’s product development programs and announced financial...
May 9, 2018

Versartis Reports First Quarter 2018 Financial Results

Versartis (Nasdaq:VSAR), an endocrine-focused biopharmaceutical company, today announced financial results for the first quarter ended March 31, 2018. As quoted in...
May 4, 2018

Finjan Files Patent Infringement Complaint Against Check Point USA and Check Point Israel

Finjan Holdings Inc (NASDAQ:FNJN), a global leader in cybersecurity announced that it has filed a patent infringement lawsuit against Check...
April 30, 2018

8 Glioblastoma Treatment Stocks

With an average survival rate of 16 months, glioblastoma is the most common and deadly type of brain cancer, accounting...